Article
Effect of Oral Treatment with Pyrazole Carbohydrazide Derivatives against Murine Infection by Leishmania amazonensis
Registro en:
CHARRET, Karen S. et al. Effect of Oral Treatment with Pyrazole Carbohydrazide Derivatives against Murine Infection by Leishmania amazonensis. Am. J. Trop. Med. Hyg., v.80, n.4, p.568-573, 2009.
0002-9637
1476-1645
Autor
Charret, Karen S.
Rodrigues, Raquel F.
Bernardino, Alice M. R.
Gomes, Adriana O.
Carvalho, Adriana V.
Canto-Cavalheiro, Marilene M.
Leon, Leonor L.
Amaral, Veronica F.
Resumen
Newly synthesized pyrazole carbohydrazide derivatives with substituents X = Br/Y = NO 2 and X =
NO 2 /Y = Cl were independently investigated in the CBA mouse model of cutaneous leishmaniasis. Animals
were infected with Leishmania amazonensis and treated two weeks after the parasitic infection with the pyrazole carbohydrazides
for 45 days. Oral treatment with both compounds controlled evolution of footpad cutaneous lesions and
dissemination of parasites to draining lymph nodes. Nitric oxide generation was observed in supernatants of lymph node
cells from infected CBA mice that were treated with these compounds. The pyrazole carbohydrazide derivatives did not
show any toxicity or cause alterations in body weight, plasma concentrations of alanine aminotransferase and aspartate
aminotransferase, and urinary creatinine levels, but promoted a small decrease in blood neutrophils. These results
provide new perspectives on the development of drugs with activities against leishmaniasis.